Access reports, webinars, and recordings related to the BIO International Convention here!
Wednesday, May 9, 2018 | 11:00am EST/8:00am PDT
Clarivate Analytics, BioWorld and BIO have teamed up to offer a free webinar to take a closer look at biotech investment and the changes that are opening more options for asset investment. Our webinar takes a look back at investment trends of 2017 and the shifting landscape that now includes strong optionality between deals, partnering, and fundraising.
Wednesday, May 2, 2018 | 2:00pm EST/11:00am PDT
Advanced Partnering webinar for experienced Partnering attendees.
Hear from academic and tech transfer panelists to learn how collaborations between industry and academia drive innovation and advance new therapies.
Join this webinar to learn more about what BIO One-on-One Partnering can do for your business and explore the fundamentals of operating the system. The webinar will also provide a preview of what’s new at BIO 2018, best practices for partnering, and much more!
Access the full library of industry analysis reports and sign up to receive the upcoming report: Emerging Therapeutic Company Trends 2008-2017
*Latest Annual Report* 3rd Annual Emerging Therapeutic Company Investment and Deal Trends 2007-2016
More than 90% of our industry is made up of small companies. This report captures stats for companies with less than a $1 billion in sales and covers six main areas: venture funding, public investment (IPOs and follow-ons), licensing, M&A, and the clinical pipeline (partnered vs. partnered).
May 25 - Pharma Trends in Emerging Markets
Learn more about the promise of emerging markets by looking at the activity and trends in the pharmaceutical industry in Brazil, Russia, India, China and South Korea (BRICS).
May 16 - Applying Competitive Intelligence to Navigate the Changing Disease Landscape
In preparation for the 2017 BIO International Convention, Clarivate Analytics and BIO have teamed up to offer this free webinar where we will use neurodegenerative disease as a use case to demonstrate the critical information and analysis needed to be first in class and/or best in class for a therapy area. David Dunn, US Practice Lead and Scientific Advisor for Portfolio and Licensing, Clarivate Analytics will analyze the pipelines of three leading neurodegenerative diseases: Alzheimer’s, Parkinson’s and ALS. In this webinar David will examine current therapeutic hypotheses and the industry’s track record in finding therapies based on them.
